Skip to main content
Caplight Logo









Rapa Therapeutics

Rapa Therapeutics

Private
Rockville, MarylandHealthcare & Life Scienceshttps://www.rapatherapeutics.com/

Last Round

Grant

Oct 5, 2023

Total Funding Raised

$12.2M

Company Overview

Rapa Therapeutics is a clinical-stage biotechnology company that develops adoptive T cell immunotherapy products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

adoptive T cell therapyepigenetic reprogrammingimmunotherapycell therapybiotechautologous T cell therapysolid tumor treatmentneurodegenerative disease treatmentclinical-stage biotechvirtual control armsnext-gen immunotherapyoff-the-shelf cell therapyprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rapa Therapeutics Comparables

Compare Rapa Therapeutics with similar companies based on industry and business-model similarity.

Rapa Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WindMIL Therapeutics
82%
Cellenkos, Inc.
80%
RegCell, Inc.
78%

Rapa Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 5, 2023
VC RoundMay 25, 2023
GrantFeb 28, 2022

Rapa Therapeutics Investors

Notable investors and investment history

Rapa Therapeutics investors
InvestorRounds
The ALS AssociationGrant
NIH RADxGrant
TEDCOVC Round
ArgyleRoadVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 26, 2024

    Grew 33% QoQ from 9 to 12 employees.

  • Sep 21, 2024

    Grew 160% QoQ from 5 to 13 employees.

Rapa Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rapa Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rapa Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRockville, Maryland
Employee Range14
Year Founded2017
Last FundingOct 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?